Jonathan Eschedor

Jonathan Eschedor is a Senior Medical Science Liaison at Accord BioPharma, representing the company with the launch of their first commercial product for prostate cancer and focusing on a pipeline of biosimilars. Prior to this, Jonathan held positions such as a Nurse Practitioner at Affiliated Oncologists, LLC and 21st Century Oncology, as well as roles at Oncopeptides, Inc. and Sterling Healthcare. With a background in nursing and a focus on oncology, Jonathan brings a wealth of experience to their current role in the pharmaceutical industry.